McKesson Accelerate is a one-of-a-kind event that will bring together more than 1,000 physicians, clinicians, practice leaders and industry experts for invaluable leadership sessions, unparalleled networking opportunities, and peer-to-peer learning, all aimed at bringing the future of oncology to your practice and patients today.
April 29 – April 30, 2024 in Orlando, Florida
McKesson and The US Oncology Network optimize how oncology clinics operate, bringing value to every practice and its patients. Our objective is to make your work more efficient and effective, giving providers the freedom to focus on their patients and make informed decisions about their business.
Together, we are setting a new standard for oncology – everyday. Visit us in booth #404 to learn more, and hear from our experts.
April 4 – April 5, 2024 at the Hilton Orlando in Orlando, Florida
McKesson and The US Oncology Network champion independent practices, enabling you to deliver exceptional care and cutting-edge treatments with a personal touch that only a community provider can deliver.
Together, we are setting a new standard for oncology – everyday. Visit us in booth #203 to learn more, and hear from our experts: check out our speaker agenda here.
March 12-13 at the JW Marriott in Indianapolis, Indiana
Join us for this year's Annual Conference, where leaders and experts across the The US Oncology Network unite to share, learn, and inspire. Engage in peer-led learning and discussions on forefront oncology challenges. Gain valuable insights from lively sessions, enhancing your practice's capabilities and the connectivity that strengthens The Network. Leave with a wealth of knowledge and fresh strategies to rejuvenate your practice.
The Power of Community in action. #IndyAC24
April 27-28 at the JW Marriott, Los Angeles
It's a time when The Network's leaders, physicians, clinicians, and pharmacists come together to discuss new developments in The Network and critical issues that impact the oncology community. Connect through networking events and collaboration opportunities; discover through educational and interactive sessions; energize through leadership insights, along with industry and innovative strategies in oncology care – Get ready to experience The Power of Community. #AC23LA
Join us at the 2023 Community Oncology Conference on March 23-24 in Orlando at the Gaylord Palms. This conference is a key opportunity to meet other leaders in the community oncology space. Hear from several of our key leaders and experts from The US Oncology Network, including COA co-chair, Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology and Ben Jones, VP of Government Relations and Public Policy – Check out the agenda here.
Physicians in The Network have a voice, play a vital role in shaping the future of cancer treatment, and lead the way in the fight against cancer.
We’re dedicated to community oncology and believe that patient care in the community setting is best. Through our tailored approach and comprehensive practice management solutions, we clear the path so you can care for your patients.
Together we are McKesson and The US Oncology Network.
Physicians across the country came together for the 2022 Virtual Annual Conference for The US Oncology Network. Nearly 300 attendees joined the four-hour event to hear the latest updates on important initiatives from physician, practice and Network leadership and learn best practices from speakers across The Network.
Physicians from across the country came together in April for The Network’s 2018 Annual Conference in Phoenix, AZ. This year’s theme, “future forward: cancer care in the community,” reflected The Network’s commitment to the spectrum of innovation, from the patient’s experience to a practice’s operations. Among the expert speakers, Tait Shanafelt, MD, of Stanford Medicine, discussed physician burnout and how we can innovate around the physician experience. Attendees were also invited to participate in an Innovation Tournament, brainstorming solutions to a number of complex issues facing community oncology practices today.
The Annual Conference was hosted in conjunction with the Spring P&T Meeting, Practice Success in The Network Workshop for New Physicians, Executive Director Meeting, and Radiation Oncology Business Meeting and Educational Symposium, bringing together a wide variety of professionals for a unique opportunity to network and exchange ideas.
Physicians and leaders from across The US Oncology Network participated in speaker panels and presented on various topics at the 2018 Communication Oncology Conference in National Harbor, MD on April 12 – 13.
Joyce O’Shaughnessy, MD of Texas Oncology weighed in on the CDK4/CDK6 Protein Coding in Breast Cancer session, Houston Holmes, MD, MBA, FACP of Texas Oncology presented on CAR-T in Community Oncology Practice, and Robert M. Rifkin, MD, FACP, medical director, Biosimilars, The US Oncology Network presented on The New World of Biosimilars: From Clinical Use to Reimbursement.
In addition, Ben Jones, vice president of Government Relations and Public Policy, The US Oncology Network, joined the Washington, D.C. Update: The Latest Legislative Issues Impacting Cancer Care & Your Practice panel discussion during the general session and Debra Patt, MD, MPH, MBA, vice president, Texas Oncology, participated in the Community Oncology 101: Key Issues Impacting Patients and Practices panel discussion.
Leaders from The US Oncology Network participated in speaker panels at the ACCC 44th Annual Meeting and Cancer Center Business Summit in Washington, D.C. on March 14 – 16.
Dr. Michael Seiden, president and chief medical officer of The US Oncology Network, discussed how “big data,” workforce shortages, clinical advancements and payment reform are impacting community oncology practices nationwide. In addition, Dr. Marcus Neubauer, vice president and medical director, Payer and Clinical Services, joined the Strategies for Improving Care Coordination panel on the meeting’s quality track and Diana Verrilli, senior vice president, Strategy and Practice Solutions, took part in the Leveraging Data Collection & Quality Reporting to Drive Change panel discussion on the technology and informatics track.
In December, investigators from The US Oncology Network presented 20 abstracts, including four oral presentations, on clinical and health outcomes research studies they conducted at the 2017 American Society of Hematology (ASH) Meeting and Exposition.
In December, breast cancer experts from US Oncology Research presented results from twelve clinical trials at this year’s SABCS, including three oral presentations.
In early November, the Pharmacy and Therapeutics (P&T) committee members and Clinical Advisory Council (CAC) members from across The Network gathered in Denver, CO for the first 2017 Fall P&T Committee and Clinical Advisory Council Meeting. Members from each group were asked to participate in interactive working sessions to leverage their collective multi-disciplinary care experience, transforming the way they work together as clinical teams to provide best-in-class cancer care.
In October, The US Oncology Network hosted the 2017 Fall National Policy Board (NPB) Meeting in The Woodlands, TX. The meeting brought together more than 100 physician and practice leaders from across The Network. They heard presentations on the future of healthcare, value-based care and policy and participated in working sessions where they discussed topics on value-based care and clinical transformation.
29 APPs from across The Network attended a the three-and-a-half-day APP, CME certified, on boarding course in June. The course focused on key and current issues in the management of identified common cancers that are treated in community oncology practices including breast, lung and colorectal cancers and benign and malignant hematologic disorders. The workshop also included sessions on clinical pharmacology, symptom management, and an overview of The Network resources available to APPs.
78 advanced practice providers (APPs) from across The US Oncology Network attended JADPRO Live at the Advanced Practitioner Society for Hematology and Oncology (APSHO) Conference in Houston, TX. In addition, The Network held a pre-conference meeting where APP leads hosted best practice sharing round-tables on topics such as advance care planning, immunotherapy, oral chemotherapy, genetics, research, palliative care, surgery, survivorship, and urgent care.
In October, the 7th Annual Genetic Risk Evaluation and Testing (GREAT) Education Conference was held in Phoenix, Arizona. Attendees received updates on the rapidly advancing field of cancer genetics, hereditary cancer syndromes and high-risk recommendations for patients with hereditary syndromes, and a review of basic and complex cases. The conference was a huge success with record attendance of providers from across The US Oncology Network.
